Gland Pharma bags USFDA nod for Cangrelor for Injection
Hyderabad: Gland Pharma Limited has recently received a tentative approval from the United States Food and Drug Administration (US FDA) for Cangrelor for Injection, 50 mg/vial Single-Dose Vials."Gland Pharma believes that we are amongst one of the first to files for this product and may be eligible for 180 days of generic drug exclusivity," the company said in a release.Gland Pharma will...
Hyderabad: Gland Pharma Limited has recently received a tentative approval from the United States Food and Drug Administration (US FDA) for Cangrelor for Injection, 50 mg/vial Single-Dose Vials.
"Gland Pharma believes that we are amongst one of the first to files for this product and may be eligible for 180 days of generic drug exclusivity," the company said in a release.
Gland Pharma will launch the product with its marketing partner on receipt of final approval.
Gland Pharma, a generic injectable focused pharmaceutical company was established in 1978 in Hyderabad.
It has a wide range of injectables, including vials, ampoules, pre-filled syringes, lyophilized vials, dry powders, infusions, oncology and ophthalmic solutions a
Next Story
